GEN Exclusives

More »

GEN News Highlights

More »
Jul 3, 2007

Cinpathogen and Chinese University Form Center for Clinical and Molecular Research

  • Cinpathogen, a U.S.-based bioresearch firm, has partnered with the Institute of Biomedical Sciences at Fudan University in Shanghai to form the Fudan Cinpathogen Center for Clinical and Molecular Research.

    "By integrating Western and Chinese medical research systems,” notes Richard D. Irons, Cinpathogen's CEO, “we can advance global biomedical research and help satisfy China's growing demand for high-quality healthcare."

    The Fudan-Cinpathogen Center for Clinical and Molecular Research will bring together clinical operations, diagnostic laboratories, and access to one of the largest tissue banks dedicated to diseases of the blood and immune systems, according to the organizations. Scientists will conduct work to support diagnosis as well as protocol-driven research on the etiology, pathogenesis, and treatment of disease.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?